· Eliminates potential interferences from other proteins or contaminants due to high purity and low bioburden.
· Demonstrates excellent recovery compared to native Cystatin C.
· Ensures supply sustainability with a recombinant product, not dependent on a biological raw material.
Cystatin C is primarily used as a diagnostic marker for kidney function - routine kidney function tests measure serum Creatinine, Urea and glomular filtration rate (GFR). Serum Cystatin C is measured as part of the GFR test, as it is quicker and easier than traditional techniques of collecting urine samples over a 24 hour period. It has also been shown to not be affected by age, gender and body weight of the patient, making it the modern day diagnostic marker of choice.
This product is ideal for use in immunoassays, control and calibrator manufacture and in research and development. Full validation allows BBI to offer high reproducibility, excellent batch to batch consistency and long term supply, which can often prove troublesome with a native alternative.
Visit the BBI Solutions website (http://www.bbisolutions.com/
BBI Solutions is a leading manufacturer of raw materials and finished test platforms for the in-vitro diagnostic market. The BBI Group was founded in 1959, and has grown from a small specialist company to a global business with manufacturing sites spanning three countries.
Our range of raw materials includes human antigens, antibodies, serum and plasma products and clinical chemistry enzymes. We manufacture world renowned labels for lateral flow, ELISA assay and biosensors, including our gold nanoparticles and glucose oxidase.
BBI Solutions offer contract development and manufacturing services with a core focus on gold conjugation and lateral flow test manufacture.
BBI Solutions is part of the BBI Group.